Contents on this page
2024
Annual General Meeting 2024
| You can attend the virtual Annual General Meeting here on 17 May 2024. |
Save meeting in calendar
To the virtual Annual General Meeting |
| Agenda | Download |
The Annual General Meeting of APONTIS PHARMA AG will be held on Friday, 17 May 2024, at 10:00 a.m. (CEST).
The Annual General Meeting of the Company will be held as a virtual general meeting without the physical presence of shareholders or their proxies (except for the Company's proxies).
For duly registered shareholders and their proxies, the entire Annual General Meeting, including any speeches, the answering of questions and the voting, will be broadcast live in picture and sound on the password-protected internet service.
Via the password-protected internet service, duly registered shareholders (or their proxies) may, among other things, follow the virtual Annual General Meeting live in picture and sound and, in accordance with the procedures provided for that purpose
Unless, in exceptional cases, disclosure pursuant to section 130a para. 3 sentence 4 of the German Stock Corporation Act (AktG) may be waived, submitted statements on the items on the agenda will be made available in the password-protected internet service no later than four days prior to the Annual General Meeting, i.e. no later than midnight (CEST) on 12 May 2024.
There are currently no countermotions.
LOGIN to the password-protected internet service
The personal access data required for this purpose will be sent to the shareholders or their proxies after registration for the Annual General Meeting. Persons other than the registered shareholders or their proxies cannot follow the Annual General Meeting on the internet.
In case of subsequent (sub-)authorisation, the following applies: The use of the password-protected internet service by the proxy requires that the proxy receives the corresponding access data.
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG):
Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@linkmarketservices.eu.
The Annual General Meeting of the Company will be held as a virtual general meeting without the physical presence of shareholders or their proxies (except for the Company's proxies).
For duly registered shareholders and their proxies, the entire Annual General Meeting, including any speeches, the answering of questions and the voting, will be broadcast live in picture and sound on the password-protected internet service.
Via the password-protected internet service, duly registered shareholders (or their proxies) may, among other things, follow the virtual Annual General Meeting live in picture and sound and, in accordance with the procedures provided for that purpose
- exercise their voting rights by means of electronic postal voting,
- grant a power of attorney to a third party or a power of attorney with instructions to the proxies of the Company,
- submit statements on the items on the agenda in text form or in video format by means of electronic communication by midnight (CEST) on 11 May 2024,
- from approximately one hour prior to the start of the Annual General Meeting, register to speak via the virtual speaking table and subsequently exercise the right to speak; the right to speak includes, in particular, the right to submit motions and nominations pursuant to section 118a para. 1 sentence 2 no. 3 of the German Stock Corporation Act (AktG), as well as the right to request information pursuant to section 131 para. 1 of the German Stock Corporation Act (AktG); and
- declare an objection to a resolution of the Annual General Meeting for the record of the notary public during the Annual General Meeting.
Unless, in exceptional cases, disclosure pursuant to section 130a para. 3 sentence 4 of the German Stock Corporation Act (AktG) may be waived, submitted statements on the items on the agenda will be made available in the password-protected internet service no later than four days prior to the Annual General Meeting, i.e. no later than midnight (CEST) on 12 May 2024.
There are currently no countermotions.
LOGIN to the password-protected internet service
The personal access data required for this purpose will be sent to the shareholders or their proxies after registration for the Annual General Meeting. Persons other than the registered shareholders or their proxies cannot follow the Annual General Meeting on the internet.
In case of subsequent (sub-)authorisation, the following applies: The use of the password-protected internet service by the proxy requires that the proxy receives the corresponding access data.
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG):
Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@linkmarketservices.eu.
Agenda and convening of the Annual General Meeting
Information
on Agenda item 4
on Agenda item 4
Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212
Annual Report 2023 incl. Group financial statements, Group management report and report of the Supervisory Board
APONTIS PHARMA AG Individual Statements 2023 (German only)
Articles of Association (German only)
Power of attorney to Company's proxies
Power of attorney to a third person
Revocation
of a power of attorney
of a power of attorney
Notes on data protection
2023
Annual General Meeting 2023
The Annual General Meeting of APONTIS PHARMA AG was held on Friday, 12 May 2023, at 10:00 a.m. (CEST).
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG): Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@better-orange.de.
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG): Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@better-orange.de.
Votings Results – German only
Speech of the Board (German only)
Annual Report 2022 incl. Group financial statements, Group management report and report of the Supervisory Board
APONTIS PHARMA AG Individual Statements 2022 (German only)
Articles of Association (German only)
Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212
Agenda and convening of the Annual General Meeting
Information on data protection
Power of attorney to the proxies of the Company
Power of attorney to a third person
Revocation of a power of attorney
2022
Annual General Meeting 2022
The annual general meeting of APONTIS PHARMA AG was held on Thursday, May 12, 2022, at 10.00 a.m. (CEST).The Company’s annual general meeting was held in virtual form without the physical presence of the shareholders or their representatives (with the exception of the voting representatives appointed by the Company).
Votings Results – German only
Convening and agenda of the virtual AGM 2022
Information according to § 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018_1212
Resumes Supervisory Board Candidates
Resumes Supervisory Board
Annual financial statements 2021
Annual financial statement 2021 (German only)
Articles of Association of APONTIS PHARMA AG (German only)
Proxy to a person of your choice
Power of attorney to Company's proxies
Revocation
Notes on data protection
